483 related articles for article (PubMed ID: 17709884)
1. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
2. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
[TBL] [Abstract][Full Text] [Related]
3. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
[TBL] [Abstract][Full Text] [Related]
9. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
11. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
12. XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products.
Li H; Zheng X; Wang H; Zhang Y; Xin H; Chen X
Eur J Pharmacol; 2010 Feb; 627(1-3):340-7. PubMed ID: 19895808
[TBL] [Abstract][Full Text] [Related]
13. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
[TBL] [Abstract][Full Text] [Related]
14. Swertiamarin mitigates nephropathy in high-fat diet/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products.
Parwani K; Patel F; Bhagwat P; Dilip H; Patel D; Thiruvenkatam V; Mandal P
Arch Physiol Biochem; 2024 Apr; 130(2):136-154. PubMed ID: 34657540
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Metz TO; Alderson NL; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
[TBL] [Abstract][Full Text] [Related]
17. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
Forbes JM; Thallas V; Thomas MC; Founds HW; Burns WC; Jerums G; Cooper ME
FASEB J; 2003 Sep; 17(12):1762-4. PubMed ID: 12958202
[TBL] [Abstract][Full Text] [Related]
18. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
20. [Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
Li XZ; Yan HD; Wang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):525-31. PubMed ID: 21608227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
